• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 effect on TB presentation and outcome.

作者信息

Marchese V, Formenti B, Marchese L, Gregori N, Gardini G, Russo G, Bona F, Di Rosario G, Gulletta M, Tomasoni L R, Castelli F, Matteelli A

机构信息

Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy, WHO Collaborating Center for TB/HIV Co-infection and the TB Elimination Strategy, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

出版信息

Int J Tuberc Lung Dis. 2022 Apr 1;26(4):375-377. doi: 10.5588/ijtld.22.0036.

DOI:10.5588/ijtld.22.0036
PMID:35351245
Abstract
摘要

相似文献

1
COVID-19 effect on TB presentation and outcome.新冠病毒病对结核病表现及转归的影响。
Int J Tuberc Lung Dis. 2022 Apr 1;26(4):375-377. doi: 10.5588/ijtld.22.0036.
2
Chemotherapy of tuberculosis: TB or not TB?结核病的化疗：是结核病还是非结核病？
Nurs Mirror. 1981 Jul 29;153(5):32-3.
3
Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa.新疾病带来的旧威胁的机遇：将 COVID-19 应对工作扩展到南非的结核病。
S Afr Med J. 2020 Nov 5;110(12):1160-1167. doi: 10.7196/SAMJ.2020.v110i12.15126.
4
Pulmonary TB: not quite a disease of the past.肺结核：并非完全是过去的疾病。
RN. 1975 Feb;38(2):77-80, 82.
5
Can we treat untreatable TB?我们能治疗无法治愈的结核病吗？
Expert Rev Anti Infect Ther. 2012 Nov;10(11):1239.
6
The growing renaissance in TB drug study.结核病药物研究领域日益兴起的复兴之势。
Proj Inf Perspect. 2008 Apr(45):24-7.
7
For drug resistant (DR) TB is there any strength in the old warriors yet?对于耐多药结核病而言，这些“老斗士”是否仍有力量？
Indian J Tuberc. 2019 Oct;66(4):496-498. doi: 10.1016/j.ijtb.2019.03.002. Epub 2019 Mar 26.
8
Pulmonary tuberculosis: clinical features and patient management.
Nurs Stand. 2011;25(47):48-56; quiz 58.
9
Streptomycin susceptibility and MDR-TB: can we refine the definition of XDR-TB?
Am J Respir Crit Care Med. 2011 Jan 15;183(2):278; author reply 279. doi: 10.1164/ajrccm.183.2.278.
10
Targeting persistence: the next frontier in TB drug development.靶向潜伏感染：结核病药物研发的新前沿
GMHC Treat Issues. 2003 Oct;17(10):5.

引用本文的文献

1
Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States.美国 25 个司法管辖区横断面样本中 333 例结核病和 COVID-19 患者的特征和死亡情况。
Emerg Infect Dis. 2023 Oct;29(10):2016-2023. doi: 10.3201/eid2910.230286. Epub 2023 Aug 30.